Correlation Between Design Therapeutics and Denali Therapeutics
Can any of the company-specific risk be diversified away by investing in both Design Therapeutics and Denali Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Design Therapeutics and Denali Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Design Therapeutics and Denali Therapeutics, you can compare the effects of market volatilities on Design Therapeutics and Denali Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Design Therapeutics with a short position of Denali Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Design Therapeutics and Denali Therapeutics.
Diversification Opportunities for Design Therapeutics and Denali Therapeutics
0.24 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Design and Denali is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Design Therapeutics and Denali Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Denali Therapeutics and Design Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Design Therapeutics are associated (or correlated) with Denali Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Denali Therapeutics has no effect on the direction of Design Therapeutics i.e., Design Therapeutics and Denali Therapeutics go up and down completely randomly.
Pair Corralation between Design Therapeutics and Denali Therapeutics
Given the investment horizon of 90 days Design Therapeutics is expected to generate 1.42 times more return on investment than Denali Therapeutics. However, Design Therapeutics is 1.42 times more volatile than Denali Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Denali Therapeutics is currently generating about -0.4 per unit of risk. If you would invest 357.00 in Design Therapeutics on January 26, 2024 and sell it today you would earn a total of 8.00 from holding Design Therapeutics or generate 2.24% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 95.45% |
Values | Daily Returns |
Design Therapeutics vs. Denali Therapeutics
Performance |
Timeline |
Design Therapeutics |
Denali Therapeutics |
Design Therapeutics and Denali Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Design Therapeutics and Denali Therapeutics
The main advantage of trading using opposite Design Therapeutics and Denali Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Design Therapeutics position performs unexpectedly, Denali Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Denali Therapeutics will offset losses from the drop in Denali Therapeutics' long position.Design Therapeutics vs. Terns Pharmaceuticals | Design Therapeutics vs. Amylyx Pharmaceuticals | Design Therapeutics vs. Acumen Pharmaceuticals | Design Therapeutics vs. Inozyme PharmaInc |
Denali Therapeutics vs. Terns Pharmaceuticals | Denali Therapeutics vs. Amylyx Pharmaceuticals | Denali Therapeutics vs. Acumen Pharmaceuticals | Denali Therapeutics vs. Inozyme PharmaInc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |